1.
Chem Commun (Camb)
; 49(44): 5031-3, 2013 Jun 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23615723
RESUMO
AH197, a trinuclear Ru(III)/Pt(II) metal complex, is strikingly more effective than the hallmark anticancer drug cisplatin and the Ru(III) clinical candidate NAMI-A in its binding to RNA and inhibition of primer DNA synthesis. Heteromultinuclear complexes could potentially serve as far better chemotherapeutics than mononuclear complexes.